United Kingdom · Medical devices startup

GlySure Ltd

GlySure Ltd is a UK-based medical technology company specializing in continuous glucose monitoring systems for hospital use, particularly in intensive care units.

Funding reportedLast round: Series C

Medical devicesAbingdon, United Kingdom

About GlySure Ltd

GlySure Ltd is a UK-based medical technology company specializing in continuous glucose monitoring systems for hospital use, particularly in intensive care units.

Founded in 2006 and headquartered in Abingdon, Oxfordshire, the company focuses on developing innovative solutions to support tight glycemic control in critically ill patients. The core product is a continuous intravascular glucose monitoring system that utilizes a proprietary optical fluorescence sensor. This system allows ICU clinicians to safely implement intensive insulin therapy by providing real-time blood glucose readings throughout a patient's stay in the ICU. GlySure's technology is designed to enhance patient care in hospital settings, specifically targeting the needs of ICU clinicians.

What company datasets say GlySure Ltd raised

Funding, as reported

Reported in all24.4Min the source's currency
Rounds2
Last roundSeries C
Last round size13.6M
Last round dateNov 2012
Investors listed4

The company, in detail

What they build

Known for

user experiencedata protectionrandom number generatorepic graphicsonline casinoslot gamemultiplierstransaction methodslow minimum depositrng systemsensational winseasy transactionse-walletsmedical equipment manufacturingpc compatiblemobile access

Built with from their website

ShareThisFlexSliderjQueryFlickityGoogle AnalyticsAmazon AWSGoogle Hosted Libraries

Sector
Medical devices
Industry code
NAICS 71312, 334510, SIC 3845
Region
England
Revenue
3M a year, as listed
Full record
Every detail in the company directory

Medical devices in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put GlySure Ltd in front of investors. Or tell us what we have wrong.